Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

OBJECTIVE: To assess the utility and safety of rituximab in pediatric autoimmune and inflammatory disorders of the CNS. METHODS: Multicenter retrospective study. RESULTS: A total of 144 children and adolescents (median age 8 years, range 0.7–17; 103 female) with NMDA receptor (NMDAR) encephalitis (n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dale, Russell C., Brilot, Fabienne, Duffy, Lisa V., Twilt, Marinka, Waldman, Amy T., Narula, Sona, Muscal, Eyal, Deiva, Kumaran, Andersen, Erik, Eyre, Michael R., Eleftheriou, Despina, Brogan, Paul A., Kneen, Rachel, Alper, Gulay, Anlar, Banu, Wassmer, Evangeline, Heineman, Kirsten, Hemingway, Cheryl, Riney, Catherine J., Kornberg, Andrew, Tardieu, Marc, Stocco, Amber, Banwell, Brenda, Gorman, Mark P., Benseler, Susanne M., Lim, Ming
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117174/
https://ncbi.nlm.nih.gov/pubmed/24920861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000570
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados